Trans-Hit Bio Collaboration with Biokaizen on the Development of Blood-Based Diagnostics for Alzheimer’s Disease yields a Presentation at the Alzheimer’s Association International Conference.
Montreal, July 1st, 2016 - The results of studies conducted by Biokaizen Lab, an emerging leader in personalized diagnostics that has been actively collaborating with Trans-Hit since 2013, will be presented at the 2016 Alzheimer’s Association International Conference on Wednesday, July 27, 2016.These studies aimed to develop a serum-based biomarker score for detecting molecular alterations of cognitive decline that occur throughout the continuum of Alzheimer’s disease pathophysiology especially for the early phases of cognitive decline. Poster presentation
About Biokaizen Lab
BioKaizen Lab, located in Monthey, Switzerland, owns unmatched biomarker discovery methods based on a platform technology able to measure tens of thousands of biomolecules in a single drop of blood and their personalization according to genetic differences and a patient’s testing history. These methods of personalized diagnosis derived from the Biological Passport program solve today’s dilemma that exists between the necessity to diagnose a disease early and the concomitant risk of over-diagnosis and over-treatment. Relying on the longstanding experience in biotechnology and clinical laboratory services of its management team, BioKaizen aims to make predictive, personalized, preventive, participatory P4 medicine easily accessible to everyone.
About Trans-Hit Bio
Trans-Hit Bio is the worldwide biospecimen access CRO with the most extensive collection capability for biospecimens and clinical samples through an unrivaled worldwide partnered-network of state-of-the-art biorepositories. We facilitate direct interactions between our customers and academic biobanks allowing the scientific and medical expertise of academics to be drawn upon and leveraged. We take the time to carefully assess your needs, and consider your specific requirements for biospecimen collections and associated medical data. The company, led by a team of scientists with a solid background in biomedical research advises you and provide you with the best solutions to help you design your biospecimen requests in variousfields including oncology, infectiology, CNS diseases. We provide continuous support throughout the process from your initial request to the moment you receive the samples in your lab and beyond.